Navigation Links
BGI Tech lancerer Human Whole Exome-sekvenseringstjeneste på Complete Genomics avancerede platform
Date:7/22/2014

CAMBRIDGE, Massachusetts og SHENZHEN, Kina, 22. juli 2014 /PRNewswire/ -- BGI Tech Solutions Co., LTD, (BGI Tech), et datterselskab af BGI, verdens største genomics-organisation, annoncerede den globale lancering af en ny human whole exome-sekvenseringstjeneste baseret på Complete Genomics brancheførende platform.

Complete Genomics, højt anset i branchen for at levere patenterede sekvenseringsteknologier med 99,999 % præcision og højfølsom registrering af alle typer varianter, blev købt af BGI i 2013. Mere end 15.000 genomer er sekvenseret og analyseret på Complete Genomics platform til dato. BGI med sin omfattende genom- og exome-sekvenseringsekspertise har forbedret Complete Genomics platform yderligere til nu at kunne levere solide og hurtige human whole exome-sekvenseringstjenester, der udnytter de iboende styrker i den platform.

Whole exome-sekvensering på Complete Genomics platform, der bliver tilgængelig i dag til en introduktionspris på kun USD 599 pr. prøve indtil slutningen af 2014, garanterer 100X gennemsnitlig sekvenseringsdybde for målregioner og omfatter analyse for SNP/InDel-kald og anmærkning samt SNP-validering. Derudover leverer BGI Tech en dedikeret arbejdsproces og pipeline, som adresserer design og udfordringer for studier af kræft, der muliggør følsom registrering af somatiske varianter ved tilstedeværelse af tumorheterogenitet.

Yingrui Li, adm. direktør for BGI Tech, sagde, "Vi er glade for at kunne stille denne ekstremt nøjagtige til rådighed for vores mere end 30.000 kunder over hele verden og til det globale forskningssamfund Vi er i øjeblikket ved at udvikle yderligere applikationer til denne platform, f.eks. transkriptomanalyse og genotype ved sekvensering og ser frem til at annoncere disses tilgængelighed snart."

Yderligere oplysninger fås på bgitechsolutions.com/complete-genomics-offers.

Om BGI Tech

BGI Tech, et datterselskab af BGI, verdens største genomics-organisation, leverer løsninger til sekvensering og bioinformatiktjenester til globale biomedicinske, landbrugsrelaterede og miljøkunder. Med branchens mest omfattende avancerede teknologier leverer BGI Tech resultater, der er hurtige, billige og af høj kvalitet, som gør det muligt for forskere at opnå videnskabelige gennembrud. BGI Tech har leveret førsteklasses tjenester til mere end 10.000 forskningsinstitutter og 30.000 videnskabspartnere, som har resulteret i mere end 600 publikationer, herunder 100 i de bedste magasiner som Nature og Science. Yderligere oplysninger fås på bgitechsolutions.com.

Kontakter

Bicheng Yang, Ph.D.
Public Communication Officer
BGI
+86-755-82639701
yangbicheng@genomics.cn

www.genomics.cn

Joyce Peng, Ph.D.
Marketing Director
BGI Tech & BGI Americas
+1-626-222-5584
joyce.peng@bgiamericas.com

www.bgitechsolutions.com

 


'/>"/>
SOURCE BGI Tech Solutions Co., LTD.
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Integrated 3-D Imaging Facilitates Human Face Transplantation
2. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
3. Singapore scientists lead human embryonic stem cell study
4. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
5. ReproCELL Licensed Commercialization Right on Human iPS Cell Derived Hepatocytes - Expected Launch in Q2 2012
6. Cepheid Welcomes Senior Vice President of Human Resources
7. deCODE Genetics, in Collaboration with Academic Colleagues, Discovers Three Variants in the Sequence of the Human Genome that Affect the Risk of Thyroid Cancer
8. Foundation for Angelman Syndrome Therapeutics (FAST) Funds Human Clinical Trial
9. Successful human tests for first wirelessly controlled drug-delivery chip
10. First successful human results achieved: Implantable wireless microchip drug delivery device
11. Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/24/2016)... -- Regular discussions on a range of subjects including policies, debt ... said Poloz. Speaking at a lecture to the ... pointed to the country,s inflation target, which is set by ... "In certain areas there needs to ... goals, why not sit down and address strategy together?" ...
(Date:6/23/2016)... ... 23, 2016 , ... UAS LifeSciences, one of the leading ... UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing high ... its list of well-respected retailers. This list includes such fine stores as Whole ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):